Researchers found the new anti-aging drug reduced participants’ biological age, measured by ‘aging clocks,’ 100% of the time.
Clinical trials continue to drive drug development in modern medicine, yet most Americans never hear about them from the person they trust most with their health. According to a 2025 survey, only 8 ...
GlobalData on MSN
Podcast: Beyond AI: Why patient-centric clinical trials matter now
Clinical trial experts discuss how they are navigating the push to adopt new technologies while centring patients in studies.
NetraAI’s biological and clinical signatures successfully boosted the accuracy of all eight evaluated algorithms across every single dataset ...
“People with rare cancers face a world without standard treatment roadmaps, clear prognoses, or strong patient support ...
Identifying Health Information Technology Needs of Oncologists to Facilitate the Adoption of Genomic Medicine: Recommendations From the 2016 American Society of Clinical Oncology Omics and Precision ...
As drug developers strive for rapid cancer treatment approvals, real patients are left behind. Experts are calling for a ...
Beyond terms like "met endpoint" or "statistically significant," understanding how to read clinical trial results and what ...
America has never had more promising science – or a greater opportunity to cure disease. Yet every day, patients wait because ...
Women were generally excluded from clinical trials until the 1990s; in 1993, the NIH inclusion policy was codified into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results